Trial Profile
Effect of bortezomib + dexamethasone + cyclophosphamide + etoposide + cisplatin (V-DCEP) in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Cisplatin; Cyclophosphamide; Dexamethasone; Etoposide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 11 May 2015 New trial record